Study number 8533-146
Dates
Oct 20 2024-Dec 07 2024
Location
Daytona Beach, Florida
Age
18-55
Gender
Male/Female
Compensation
$8,782
Group
Pt 2
The investigational drug in this research study has been approved for the treatment of locally advanced or metastatic ROS1-positive non-small cell lung cancer.
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Non-Smoking Men and Women of Non-Childbearing Potential, age 18-55
- Body Mass Index between 18-30
- Study involves 1 stay of 20 overnights and 1 phone call
- Compensation up to $8,782 may be provided for time and participation
- Refer a friend to receive up to $300 per qualified referral
Call Now to Schedule Your Screening Appointment!
Check-in: Oct 20
Check-out: Nov 9
Phone Call: Dec 7